Nuzenio

Context Therapeutics

Context Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Context Therapeutics Inc (CNTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 09:16:53 GMTContext Therapeutics Inc. Stock 12‑Month Price Target Cut to $4.56, Implies 557% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:13 GMTContext scraps bispecific T-cell engager program to extend cash runway deeper into 2027 - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 09:55:15 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - BenzingaBenzinga · Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics (NASDAQ:CNTX) Announces Earnings Results, Misses Expectations By $0.05 EPS - MarketBeatMarketBeat · Thu, 06 Aug 2026 01:20:01 GMTContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:44:29 GMTContext Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:14:11 GMT

Timeline

Fri, 07 Aug 2026 09:16:53 GMTContext Therapeutics Inc (CNTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thu, 06 Aug 2026 23:20:13 GMTContext Therapeutics Inc. Stock 12‑Month Price Target Cut to $4.56, Implies 557% Upside - TradingView
Thu, 06 Aug 2026 09:55:15 GMTContext scraps bispecific T-cell engager program to extend cash runway deeper into 2027 - Fierce Biotech
Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - Benzinga
Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - stocktitan.net
Thu, 06 Aug 2026 01:20:01 GMTContext Therapeutics (NASDAQ:CNTX) Announces Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Context Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.